Zuranolone Patent Expiration

Zuranolone is Used for treating postpartum depression. It was first introduced by Biogen Inc in its drug Zurzuvae on Oct 31, 2023.


Zuranolone Patents

Given below is the list of patents protecting Zuranolone, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Zurzuvae US10172871 19-nor C3, 3-disubstituted C21-N-pyrazolyl steroids and methods of use thereof Apr 17, 2034 Biogen Inc
Zurzuvae US10342810 19-nor C3, 3-disubstituted C21-N-pyrazolyl steroids and methods of use thereof Apr 17, 2034 Biogen Inc
Zurzuvae US11236121 Crystalline 19-nor C3,3-disubstituted C21-N-pyrazolyl steroid Aug 23, 2037 Biogen Inc
Zurzuvae US11884696 Crystalline 19-nor C3,3-disubstituted C21-n-pyrazolyl steroid Dec 24, 2037 Biogen Inc
Zurzuvae US9512165 19-nor C3, 3-disubstituted C21-N-pyrazolyl steroids and methods of use thereof Apr 17, 2034 Biogen Inc


Coming Soon

Patent Strength Analyzer

Will this be useful for you?

YesNo

Thank you for your response 🥳